SOMERVILLE, Mass., September 27, 2024--bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has completed the filing of its Form 10-Q for the quarter ended June 30, 2024 (the "Q2 2024 Form 10-Q") ...

Back in 2019 and early 2020, bluebird bio stock was between $40 and $50 a share, and the latest quote is 48 cents. This ...

After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a ...

The company has not yet seen the financial payoff from its scientific breakthroughs — and it says it is continuing to lose ...

(BLUE) plans to reduce workforce by 25%, optimize cost structure, focus on commercial launches, and aim for cash flow ...

Bluebird bio, Inc. (NASDAQ:BLUE) announced it is implementing a restructuring intended to optimize its cost structure and ...

About a month after reporting it’s had a tough time starting enough patients on its treatments, bluebird bio announced it ...

Bluebird Bio Inc. announced plans to cut about a quarter of its workforce as the biotech confronts a difficult environment ...

Bluebird bio will lay off about 25% of its workforce, or 95 employees, the gene therapy maker said on Tuesday, in a second major restructuring in two years as the company focuses on launching its ...

Gene therapy company Bluebird Bio on Tuesday announced a 25% reduction of its workforce as part of a restructuring.

On Thursday, bluebird bio Inc (BLUE) stock saw a modest uptick, ending the day at $0.5 which represents a slight increase of $0.02 or 4.17% from the prior close of $0.48. The stock opened at $0.51 and ...